SDGR
SDGR
NASDAQ · Health Care

Schrodinger Inc

$27.36
-2.17 (-7.35%)
Financial Highlights (FY 2026)
Revenue
260.53M
Net Income
-105,148,739
Gross Margin
55.7%
Profit Margin
-40.4%
Rev Growth
+12.2%
D/E Ratio
—
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 55.7% 55.7% 40.8% 40.8%
Operating Margin -65.2% -58.7% 22.5% 22.3%
Profit Margin -40.4% -38.3% 15.1% 13.8%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 260.53M 232.14M 163.11M 186.76M
Gross Profit 145.22M 129.39M 66.53M 76.18M
Operating Income -169,942,076 -136,280,734 36.67M 41.60M
Net Income -105,148,739 -84,321,362 24.68M 25.68M
Gross Margin 55.7% 55.7% 40.8% 40.8%
Operating Margin -65.2% -58.7% 22.5% 22.3%
Profit Margin -40.4% -38.3% 15.1% 13.8%
Rev Growth +12.2% +12.2% +7.9% -0.8%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 0 296.44M 283.20M
Total Equity — — 845.86M 810.86M
D/E Ratio — — 0.35 0.35
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -163,806,495 -138,658,264 46.19M 57.89M
Free Cash Flow — — 39.37M 27.08M